FDA clears Pluristem radiation treatment for emergency use

HAIFA, Israel (Reuters) – Pluristem Therapeutics Inc, a developer of placenta-based stem cell products, said the U.S. Food and Drug Administration has cleared the emergency use of its therapy to treat acute radiation exposure in a nuclear event.


Source: Reuters Health

Leave a Reply

Your email address will not be published. Required fields are marked *